270 related articles for article (PubMed ID: 31464129)
1. Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.
Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB
J Org Chem; 2019 Sep; 84(18):11493-11512. PubMed ID: 31464129
[TBL] [Abstract][Full Text] [Related]
2. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the antimicrobial mechanism of mutacin 1140.
Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
[TBL] [Abstract][Full Text] [Related]
4. A Chemical Biology Approach to Understanding Molecular Recognition of Lipid II by Nisin(1-12): Synthesis and NMR Ensemble Analysis of Nisin(1-12) and Analogues.
Dickman R; Danelius E; Mitchell SA; Hansen DF; Erdélyi M; Tabor AB
Chemistry; 2019 Nov; 25(64):14572-14582. PubMed ID: 31599485
[TBL] [Abstract][Full Text] [Related]
5. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of bicyclic alkene-/alkane-bridged nisin mimics by ring-closing metathesis and their biochemical evaluation as lipid II binders: toward the design of potential novel antibiotics.
Ghalit N; Reichwein JF; Hilbers HW; Breukink E; Rijkers DT; Liskamp RM
Chembiochem; 2007 Sep; 8(13):1540-54. PubMed ID: 17674393
[TBL] [Abstract][Full Text] [Related]
7. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
9. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
't Hart P; Oppedijk SF; Breukink E; Martin NI
Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
[TBL] [Abstract][Full Text] [Related]
11. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
[TBL] [Abstract][Full Text] [Related]
12. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
Tol MB; Morales Angeles D; Scheffers DJ
Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
[TBL] [Abstract][Full Text] [Related]
13. An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.
Zhao X; Yin Z; Breukink E; Moll GN; Kuipers OP
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179527
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Escano J; Ravichandran A; Salamat B; Smith L
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
[TBL] [Abstract][Full Text] [Related]
16. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
Paiva AD; Breukink E; Mantovani HC
Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
[TBL] [Abstract][Full Text] [Related]
17. Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity.
Panina IS; Balandin SV; Tsarev AV; Chugunov AO; Tagaev AA; Finkina EI; Antoshina DV; Sheremeteva EV; Paramonov AS; Rickmeyer J; Bierbaum G; Efremov RG; Shenkarev ZO; Ovchinnikova TV
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674846
[TBL] [Abstract][Full Text] [Related]
18. Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound.
Koopmans T; Wood TM; 't Hart P; Kleijn LH; Hendrickx AP; Willems RJ; Breukink E; Martin NI
J Am Chem Soc; 2015 Jul; 137(29):9382-9. PubMed ID: 26122963
[TBL] [Abstract][Full Text] [Related]
19. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Bonelli RR; Schneider T; Sahl HG; Wiedemann I
Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
[TBL] [Abstract][Full Text] [Related]
20. Docking and molecular dynamics simulations of the ternary complex nisin2:lipid II.
Mulholland S; Turpin ER; Bonev BB; Hirst JD
Sci Rep; 2016 Feb; 6():21185. PubMed ID: 26888784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
